Involvement of N-components in lung cancer
Ceron, L.; Wang, K.P.
Monaldi Archives for Chest Disease 52(6): 540-543
1997
ISSN/ISBN: 1122-0643 PMID: 9550862 Document Number: 477522
Document emailed within 1 workday
Related Documents
Yoneyama, T.; Tsuchiya, R.; Miyazawa, N.; Naruke, T.; Suemasu, K. 1985: Surgical problems in lung cancer with chest wall involvement Kyobu Geka. Japanese Journal of Thoracic Surgery 38(5): 355-360Kanai, K.; Kondo, E. 1970: Separation and properties of mycobactericidal components from the lung granular fraction of BCG-revaccinated guinea pigs. IV. Characteristics as the components of the membrane structure Kekkaku: 45(6): 171-175
Chen, W.-h.; Wang, C.; Zhang, Y.-h.; Yang, Y.-h.; Zhan, H.-y.; Zhang, L.-m. 2007: Influence of overexpressed coagulant and fibrolytic components in tumor tissues on the prognosis of non-small cell lung cancer Zhonghua Yi Xue Za Zhi 87(45): 3228-3232
Zharkov, V.V. 1990: Prognostic significance of metastatic involvement of regional lymph nodes in lung cancer Voprosy Onkologii 36(1): 58-62
Tondini, M.; Rocco, G.; Bianchi, C.; Severi, C.; Corbellini, D. 1995: Intracavitary cisplatin (CDDP) in the treatment of metastatic pericardial involvement from breast and lung cancer Monaldi Archives for Chest Disease 50(2): 86-88
Crisci, R.; Coloni, G.F. 1989: Lung cancer with mediastinal lymph node involvement. Results of the combination of surgery and radiotherapy Annales de Chirurgie 43(8): 663-667
Galstian, G.M.; Glasko, E.N.; Gorodetskiĭ, V.M.; Grzhimolovskiĭ, A.V.; Danishian, K.I.; Demidova, I.A.; Kaplanskaia, I.B.; Kesel'man, S.A.; Kliasova, G.A.; Liubimova, L.S. 2003: Lung biopsy in the diagnosis of causes of lung involvement in hemoblastosis Terapevticheskii Arkhiv 75(10): 57-64
Narula, N.; Narula, T.; Mira-Avendano, I.; Wang, B.; Abril, A. 2018: Interstitial lung disease in patients with mixed connective tissue disease: pilot study on predictors of lung involvement Clinical and Experimental Rheumatology 36(4): 648-651
Hillerdal, G. 1999: Recommendations by the Swedish lung cancer group. Shorter waiting time is a quality requirement in the management of lung cancer Lakartidningen 96(43): 4691
Levin, W.J.; Press, M.F.; Gaynor, R.B.; Sukhatme, V.P.; Boone, T.C.; Reissmann, P.T.; Figlin, R.A.; Holmes, E.C.; Souza, L.M.; Slamon, D.J. 1995: Expression patterns of immediate early transcription factors in human non-small cell lung cancer. the Lung Cancer Study Group Oncogene 11(7): 1261-1269
McCormack, V.A.; Hung, R.J.; Brenner, D.R.; Bickeböller, H.; Rosenberger, A.; Muscat, J.E.; Lazarus, P.; Tjønneland, A.; Friis, Søren.; Christiani, D.C.; Chun, E-Mi.; Le Marchand, L.; Rennert, G.; Rennert, H.S.; Andrew, A.S.; Orlow, I.; Park, B.; Boffetta, P.; Duell, E.J. 2011: Aspirin and NSAID use and lung cancer risk: a pooled analysis in the International Lung Cancer Consortium (ILCCO) Cancer Causes and Control: Ccc 22(12): 1709-1720
Evans, W.K. 1997: Cost-effectiveness of gemcitabine in stage IV non-small cell lung cancer: an estimate using the Population Health Model lung cancer module Seminars in Oncology 24(2 Suppl 7: S7
Miyamoto, T.; Inoue, M.; Tanemura, M.; Yamaguchi, M.; Irei, T.; Tamaru, K.; Seo, S.; Misumi, T.; Shimizu, W.; Suzuki, T.; Onoe, T.; Sudo, T.; Shimizu, Y.; Hinoi, T.; Tashiro, H. 2018: A Resectable Case of TS-1 Therapy Useful in Distinguishing Primary Lung Cancer from Lung Metastases of Pancreatic Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 45(1): 88-90
Perng, R.P.; Chien, K.Y.; Chen, K.Y. 1989: Combined modality treatment for non-small cell lung cancer. Lung Cancer Study Group Zhonghua Yi Xue Za Zhi 43(4): 217-222
El-Akawi, Z.J.; Nusier, M.K.; Zoughool, F.E. 2006: Relationship between alpha-1 antitrypsin deficient genotypes S and Z and lung cancer in Jordanian lung cancer patients Saudi Medical Journal 27(2): 181-184
O'Rourke, M.A.; Feussner, J.R.; Feigl, P.; Laszlo, J. 1987: Age trends of lung cancer stage at diagnosis. Implications for lung cancer screening in the elderly JAMA 258(7): 921-926
Schreiber, G.; Pitterle, D.; Kim, Y.C.; Bepler, G. 1999: Molecular genetic analysis of primary lung cancer and cancer metastatic to the lung Anticancer Research 19(2a): 1109-1115
Hijmering-Kappelle, L.B.M.; van der Wekken, A.J.; Hiltermann, T.J.N.; Groen, H.J.M. 2017: New biopsy at lung cancer progression: rational treatment of resistant lung cancer Nederlands Tijdschrift Voor Geneeskunde 161: D1229
Dhabhar, B.N.; Malhotra, H.; Advani, S.H. 1992: Incidence of lung cancer and advances in non-small cell lung cancer Journal of the Association of Physicians of India 40(7): 493
Watanabe, M.; Abe, T. 1981: Aryl hydrocarbon hydroxylase and its components in human lung microsomes Gan 72(5): 806-810